• Intel (INTC.US) stock fell 10% on weak quarterly earnings
US indices launched today's session in mixed moods as investors digest the final presidential debate which was calmer compared to the first one. Candidates did not interrupt each other and focused on variety of topics including the coronavirus pandemic, foreign policy and health care rather than personal attacks. Futures, however, remained little changed throughout the debate. Meanwhile markets are still waiting for progress regarding coronavirus aid package. US House Speaker Nancy Pelosi on Thursday noticed progress in talks with the White House for another round of financial aid amid the Covid-19 pandemic and hopes that legislation could be hammered out “pretty soon. Meanwhile US reported 76,195 new COVID-19 infections on Thursday, close to its one-day record high of 77,299 new cases on July 16, according to a Reuters analysis. Colorado, Illinois, Indiana, Montana, North Dakota, Ohio, Oklahoma and Utah all reported their biggest daily increase in cases since the pandemic started. Number of fatalities is also increasing, with 916 deaths reported on Thursday, a day after the country recorded over 1,200 new fatalities for the first time since August.
US30 – index broke below the major support at 28090 pts during yesterday’s session but sellers failed to uphold momentum and price pulled back after testing 50 SMA (green line). Today, one can see that sellers managed to halt the upward move after US open, however as long as the price sits above the aforementioned support at 28090 pts, then the upward move looks to be more probable. Next potential target for bulls is located at 28344 pts. Source: xStation5Intel (INTC.US) — reported third-quarter earnings of $1.11 per share, which came in line with market expectations. Revenue beat analysts' estimates. However chipmaker's Data Center Group, revenue dropped by 7% and miss expectations.
Intel (INTC.US) – stock launched today’s session with a bearish price gap and is currently testing local support at $48.25. Should current sentiment prevails, stock could move towards next support at $45.00. The nearest resistance lies at the $51.18 level which is additionally strengthened by 50 SMA (green line). Source: xStation5Mattel (MAT.US) stock jumped over 8.4% after company posted better-than-expected quarterly results. The toymaker reported profit of 95 cents a share and $1.63 billion in revenue while analysts expected earnings of 39 cents a share and $1.46 billion in revenue.
Gilead Sciences (GILD.US) stock rose over 4$ after Food and Drug Administration approved company's antiviral drug remdesivir as a treatment for the COVID-19. The drug had previously been authorized for emergency use.
Daily summary - Government stays shut, Market declines, crypto recovers
Extended decline at the end of a week! 🚨
US OPEN: Market extends decline at the end of the week
Constellation Energy: Mixed Results for Q3 2025
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
